Table 1.
National Cancer Institute' toxicity grading criteria version 2 and 3 for proteinuria.
Figure 1.
Selection process for clinical trials included in the meta-analysis.
Table 2.
Baseline characteristics of the 33 trials included in the meta-analysis (n = 6882).
Table 3.
Incidence for proteinuria with VEGFR-TKIs according to drugs and tumor types.
Figure 2.
Odds ratio of all-grade proteinuria associated with VEGFR-TKIs vs control.
Figure 3.
Odds ratio of high-grade proteinuria associated with VEGFR-TKIs vs control.
Figure 4.
Funnel plot of standard error by log-odds ratio for all-grade and high-grade proteinuria.